Abstract
Molecular cytopathology is a rapidly evolving field of cytopathology that provides biological information about the response to personalised therapy and about the prognosis of neoplasms diagnosed on cytological samples. Biomarkers such as circulating tumour cells and circulating tumour DNA are increasingly being evaluated in blood and in other body fluids. Such liquid biopsies are non-invasive, repeatable, and feasible also in patients with severe comorbidities. However, liquid biopsy may be challenging due to a low concentration of biomarkers. In such cases, biomarkers can be detected with highly sensitive molecular techniques, which in turn should be validated and integrated in a complex algorithm that includes tissue-based molecular assessments. The aim of this review is to provide the cytopathologist with practical information that is relevant to daily practice, particularly regarding the emerging role of circulating tumour cells in the field of predictive molecular pathology.
Journal Section:
Editor's choice
References
1.
Vigliar
E
, Malapelle
U
, de Luca
C
, Bellevicine
C
, Troncone
G
. Challenges and opportunities of next-generation sequencing: a cytopathologist’s perspective
. Cytopathology
. 2015
Oct
;26
(5
):271
–83
.
[PubMed]
0956-55072.
Scott
AM
, Wolchok
JD
, Old
LJ
. Antibody therapy of cancer
. Nat Rev Cancer
. 2012
Mar
;12
(4
):278
–87
.
[PubMed]
1474-175X3.
Hoelder
S
, Clarke
PA
, Workman
P
. Discovery of small molecule cancer drugs: successes, challenges and opportunities
. Mol Oncol
. 2012
Apr
;6
(2
):155
–76
.
[PubMed]
1574-78914.
Bellevicine
C
, Vita
GD
, Malapelle
U
, Troncone
G
. Applications and limitations of oncogene mutation testing in clinical cytopathology
. Semin Diagn Pathol
. 2013
Nov
;30
(4
):284
–97
.
[PubMed]
0740-25705.
Roy-Chowdhuri
S
, Aisner
DL
, Allen
TC
, Beasley
MB
, Borczuk
A
, Cagle
PT
, et al.. Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society
. Arch Pathol Lab Med
. 2016
Apr
;140
(11
):1267
–72
.; Epub ahead of print
.
[PubMed]
0003-99856.
Savic
S
, Tapia
C
, Grilli
B
, Rufle
A
, Bihl
MP
, de Vito Barascud
A
, et al.. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers
. Br J Cancer
. 2008
Jan
;98
(1
):154
–60
.
[PubMed]
0007-09207.
Killian
JK
, Walker
RL
, Suuriniemi
M
, Jones
L
, Scurci
S
, Singh
P
, et al.. Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling
. J Mol Diagn
. 2010
Nov
;12
(6
):739
–45
.
[PubMed]
1525-15788.
van Eijk
R
, Licht
J
, Schrumpf
M
, Talebian Yazdi
M
, Ruano
D
, Forte
GI
, et al.. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR
. PLoS One
. 2011
Mar
;6
(3
):e17791
.
[PubMed]
1932-62039.
Coley
SM
, Crapanzano
JP
, Saqi
A
. FNA, core biopsy, or both for the diagnosis of lung carcinoma: obtaining sufficient tissue for a specific diagnosis and molecular testing
. Cancer Cytopathol
. 2015
May
;123
(5
):318
–26
.
[PubMed]
1934-662X10.
Bettegowda
C
, Sausen
M
, Leary
RJ
, Kinde
I
, Wang
Y
, Agrawal
N
, et al.. Detection of circulating tumor DNA in early- and late-stage human malignancies
. Sci Transl Med
. 2014
Feb
;6
(224
):224ra24
.
[PubMed]
1946-623411.
Malapelle
U
, Pisapia
P
, Rocco
D
, Smeraglio
R
, di Spirito
M
, Bellevicine
C
, et al.. Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients
. Transl Lung Cancer Res
. 2016
Oct
;5
(5
):505
–10
.
[PubMed]
2218-675112.
Chia
PL
, Do
H
, Morey
A
, Mitchell
P
, Dobrovic
A
, John
T
. Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment
. Lung Cancer
. 2016
Aug
;98
:29
–32
.
[PubMed]
0169-500213.
Malapelle
U
, Mayo de-Las-Casas
C
, Rocco
D
, Garzon
M
, Pisapia
P
, Jordana-Ariza
N
, et al.. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients
. Br J Cancer
. 2017
Mar
;116
(6
):802
–10
.
[PubMed]
0007-092014.
Wan
JC
, Massie
C
, Garcia-Corbacho
J
, Mouliere
F
, Brenton
JD
, Caldas
C
, et al.. Liquid biopsies come of age: towards implementation of circulating tumour DNA
. Nat Rev Cancer
. 2017
Apr
;17
(4
):223
–38
.
[PubMed]
1474-175X15.
Crowley
E
, Di Nicolantonio
F
, Loupakis
F
, Bardelli
A
. Liquid biopsy: monitoring cancer-genetics in the blood
. Nat Rev Clin Oncol
. 2013
Aug
;10
(8
):472
–84
.
[PubMed]
1759-477416.
Haber
DA
, Velculescu
VE
. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA
. Cancer Discov
. 2014
Jun
;4
(6
):650
–61
.
[PubMed]
2159-827417.
Alix-Panabières
C
, Pantel
K
. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
. Cancer Discov
. 2016
May
;6
(5
):479
–91
.
[PubMed]
2159-827418.
Alix-Panabières
C
, Pantel
K
. Circulating tumor cells: liquid biopsy of cancer
. Clin Chem
. 2013
Jan
;59
(1
):110
–8
.
[PubMed]
0009-914719.
Alix-Panabières
C
, Pantel
K
. Challenges in circulating tumour cell research
. Nat Rev Cancer
. 2014
Sep
;14
(9
):623
–31
.
[PubMed]
1474-175X20.
Hong
B
, Zu
Y
. Detecting circulating tumor cells: current challenges and new trends
. Theranostics
. 2013
Apr
;3
(6
):377
–94
.
[PubMed]
1838-764021.
Klymkowsky
MW
, Savagner
P
. Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe
. Am J Pathol
. 2009
May
;174
(5
):1588
–93
.
[PubMed]
0002-944022.
Banyard
J
, Bielenberg
DR
. The role of EMT and MET in cancer dissemination
. Connect Tissue Res
. 2015
;56
(5
):403
–13
.
[PubMed]
0300-820723.
Tsai
JH
, Yang
J
. Epithelial-mesenchymal plasticity in carcinoma metastasis
. Genes Dev
. 2013
Oct
;27
(20
):2192
–206
.
[PubMed]
0890-936924.
Ghajar
CM
. Metastasis prevention by targeting the dormant niche
. Nat Rev Cancer
. 2015
Apr
;15
(4
):238
–47
.
[PubMed]
1474-175X25.
Rao
CG
, Chianese
D
, Doyle
GV
, Miller
MC
, Russell
T
, Sanders
RA
Jr, et al.. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors
. Int J Oncol
. 2005
Jul
;27
(1
):49
–57
.
[PubMed]
1019-643926.
Baccelli
I
, Schneeweiss
A
, Riethdorf
S
, Stenzinger
A
, Schillert
A
, Vogel
V
, et al.. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
. Nat Biotechnol
. 2013
Jun
;31
(6
):539
–44
.
[PubMed]
1087-015627.
Polioudaki
H
, Agelaki
S
, Chiotaki
R
, Politaki
E
, Mavroudis
D
, Matikas
A
, et al.. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
. BMC Cancer
. 2015
May
;15
(1
):399
.
[PubMed]
1471-240728.
Mani
SA
, Guo
W
, Liao
MJ
, Eaton
EN
, Ayyanan
A
, Zhou
AY
, et al.. The epithelial-mesenchymal transition generates cells with properties of stem cells
. Cell
. 2008
May
;133
(4
):704
–15
.
[PubMed]
0092-867429.
Zhang
D
, Zhao
L
, Zhou
P
, Ma
H
, Huang
F
, Jin
M
, et al.. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy
. Cancer Cell Int
. 2017
Jan
;17
(1
):6
.
[PubMed]
1475-286730.
Hou
JM
, Krebs
M
, Ward
T
, Sloane
R
, Priest
L
, Hughes
A
, et al.. Circulating tumor cells as a window on metastasis biology in lung cancer
. Am J Pathol
. 2011
Mar
;178
(3
):989
–96
.
[PubMed]
0002-944031.
Codony-Servat
J
, Rosell
R
. Cancer stem cells and immunoresistance: clinical implications and solutions
. Transl Lung Cancer Res
. 2015
Dec
;4
(6
):689
–703
.
[PubMed]
2218-675132.
Noman
MZ
, Messai
Y
, Muret
J
, Hasmim
M
, Chouaib
S
. Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
. Cancer Microenviron
. 2014
Dec
;7
(3
):153
–60
.
[PubMed]
1875-229233.
Raimondi
C
, Nicolazzo
C
, Gradilone
A
. Circulating tumor cells isolation: the “post-EpCAM era”
. Chin J Cancer Res
. 2015
Oct
;27
(5
):461
–70
.
[PubMed]
1000-960434.
Yokobori
T
, Iinuma
H
, Shimamura
T
, Imoto
S
, Sugimachi
K
, Ishii
H
, et al.. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis
. Cancer Res
. 2013
Apr
;73
(7
):2059
–69
.
[PubMed]
0008-547235.
Pantel
K
, Denève
E
, Nocca
D
, Coffy
A
, Vendrell
JP
, Maudelonde
T
, et al.. Circulating epithelial cells in patients with benign colon diseases
. Clin Chem
. 2012
May
;58
(5
):936
–40
.
[PubMed]
0009-914736.
Racila
E
, Euhus
D
, Weiss
AJ
, Rao
C
, McConnell
J
, Terstappen
LW
, et al.. Detection and characterization of carcinoma cells in the blood
. Proc Natl Acad Sci USA
. 1998
Apr
;95
(8
):4589
–94
.
[PubMed]
0027-842437.
Cen
P
, Ni
X
, Yang
J
, Graham
DY
, Li
M
. Circulating tumor cells in the diagnosis and management of pancreatic cancer
. Biochim Biophys Acta
. 2012
Dec
;1826
(2
):350
–6
.
[PubMed]
0006-300238.
Zhang
L
, Ridgway
LD
, Wetzel
MD
, Ngo
J
, Yin
W
, Kumar
D
, et al.. The identification and characterization of breast cancer CTCs competent for brain metastasis
. Sci Transl Med
. 2013
Apr
;5
(180
):180ra48
.
[PubMed]
1946-623439.
Joosse
SA
, Gorges
TM
, Pantel
K
. Biology, detection, and clinical implications of circulating tumor cells
. EMBO Mol Med
. 2015
Jan
;7
(1
):1
–11
.
[PubMed]
1757-467640.
Foy
V
, Fernandez-Gutierrez
F
, Faivre-Finn
C
, Dive
C
, Blackhall
F
. The clinical utility of circulating tumour cells in patients with small cell lung cancer
. Transl Lung Cancer Res
. 2017
Aug
;6
(4
):409
–17
.
[PubMed]
2218-675141.
Hou
JM
, Krebs
MG
, Lancashire
L
, Sloane
R
, Backen
A
, Swain
RK
, et al.. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer
. J Clin Oncol
. 2012
Feb
;30
(5
):525
–32
.
[PubMed]
0732-183X42.
Ilie
M
, Hofman
V
, Long-Mira
E
, Selva
E
, Vignaud
JM
, Padovani
B
, et al.. “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease
. PLoS One
. 2014
Oct
;9
(10
):e111597
.
[PubMed]
1932-620343.
Hou
JM
, Greystoke
A
, Lancashire
L
, Cummings
J
, Ward
T
, Board
R
, et al.. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy
. Am J Pathol
. 2009
Aug
;175
(2
):808
–16
.
[PubMed]
0002-944044.
Pore
M
, Meijer
C
, de Bock
GH
, Boersma-van Ek
W
, Terstappen
LW
, Groen
HJ
, et al.. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer
. Clin Lung Cancer
. 2016
Nov
;17
(6
):535
–42
.
[PubMed]
1525-730445.
Yu
M
, Stott
S
, Toner
M
, Maheswaran
S
, Haber
DA
. Circulating tumor cells: approaches to isolation and characterization
. J Cell Biol
. 2011
Feb
;192
(3
):373
–82
.
[PubMed]
0021-952546.
Millner
LM
, Linder
MW
, Valdes
R
Jr. Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes
. Ann Clin Lab Sci
. 2013
;43
(3
):295
–304
.
[PubMed]
1550-808047.
Danila
DC
, Samoila
A
, Patel
C
, Schreiber
N
, Herkal
A
, Anand
A
, et al.. Clinical validity of detecting circulating tumor cells by AdnaTest Assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
. Cancer J
. 2016
Sep/Oct
;22
(5
):315
–20
.
[PubMed]
1528-911748.
Saucedo-Zeni
N
, Mewes
S
, Niestroj
R
, Gasiorowski
L
, Murawa
D
, Nowaczyk
P
, et al.. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire
. Int J Oncol
. 2012
Oct
;41
(4
):1241
–50
.
[PubMed]
1791-242349.
Schneck
H
, Gierke
B
, Uppenkamp
F
, Behrens
B
, Niederacher
D
, Stoecklein
NH
, et al.; Disseminated Cancer Cell Network (DCC Net) Duesseldorf
. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
. PLoS One
. 2015
Dec
;10
(12
):e0144535
.
[PubMed]
1932-620350.
Imrich
S
, Hachmeister
M
, Gires
O
. EpCAM and its potential role in tumor-initiating cells
. Cell Adhes Migr
. 2012
Jan-Feb
;6
(1
):30
–8
.
[PubMed]
1933-691851.
Yang
MH
, Imrali
A
, Heeschen
C
. Circulating cancer stem cells: the importance to select
. Chin J Cancer Res
. 2015
Oct
;27
(5
):437
–49
.
[PubMed]
1000-960452.
Satelli
A
, Batth
I
, Brownlee
Z
, Mitra
A
, Zhou
S
, Noh
H
, et al.. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression
. Oncotarget
. 2017
Jul
;8
(30
):49329
–37
.
[PubMed]
1949-255353.
Blassl
C
, Kuhlmann
JD
, Webers
A
, Wimberger
P
, Fehm
T
, Neubauer
H
. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel
. Mol Oncol
. 2016
Aug
;10
(7
):1030
–42
.
[PubMed]
1574-789154.
Alix-Panabières
C
, Vendrell
JP
, Pellé
O
, Rebillard
X
, Riethdorf
S
, Müller
V
, et al.. Detection and characterization of putative metastatic precursor cells in cancer patients
. Clin Chem
. 2007
Mar
;53
(3
):537
–9
.
[PubMed]
0009-914755.
Somlo
G
, Lau
SK
, Frankel
P
, Hsieh
HB
, Liu
X
, Yang
L
, et al.. Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
. Breast Cancer Res Treat
. 2011
Jul
;128
(1
):155
–63
.
[PubMed]
0167-680656.
Ntouroupi
TG
, Ashraf
SQ
, McGregor
SB
, Turney
BW
, Seppo
A
, Kim
Y
, et al.. Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
. Br J Cancer
. 2008
Sep
;99
(5
):789
–95
.
[PubMed]
0007-092057.
Pantel
K
, Brakenhoff
RH
, Brandt
B
. Detection, clinical relevance and specific biological properties of disseminating tumour cells
. Nat Rev Cancer
. 2008
May
;8
(5
):329
–40
.
[PubMed]
1474-175X58.
Lianidou
ES
, Markou
A
. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges
. Clin Chem
. 2011
Sep
;57
(9
):1242
–55
.
[PubMed]
0009-914759.
Harouaka
RA
, Nisic
M
, Zheng
SY
. Circulating tumor cell enrichment based on physical properties
. J Lab Autom
. 2013
Dec
;18
(6
):455
–68
.
[PubMed]
2211-068260.
Alix-Panabières
C
. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients
. Recent Results Cancer Res
. 2012
;195
:69
–76
.
[PubMed]
0080-001561.
Fuchs
AB
, Romani
A
, Freida
D
, Medoro
G
, Abonnenc
M
, Altomare
L
, et al.. Electronic sorting and recovery of single live cells from microlitre sized samples
. Lab Chip
. 2006
Jan
;6
(1
):121
–6
.
[PubMed]
1473-019762.
Peeters
DJ
, De Laere
B
, Van den Eynden
GG
, Van Laere
SJ
, Rothé
F
, Ignatiadis
M
, et al.. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
. Br J Cancer
. 2013
Apr
;108
(6
):1358
–67
.
[PubMed]
0007-092063.
Paolillo
C
, Mu
Z
, Rossi
G
, Schiewer
MJ
, Nguyen
T
, Austin
L
, et al.. Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells
. Clin Cancer Res
. 2017
Oct
;23
(20
):6086
–93
.
[PubMed]
1078-043264.
Fischer
AH
. Circulating tumor cells: seeing is believing
. Arch Pathol Lab Med
. 2009
Sep
;133
(9
):1367
–9
.
[PubMed]
1543-216565.
Vona
G
, Sabile
A
, Louha
M
, Sitruk
V
, Romana
S
, Schütze
K
, et al.. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells
. Am J Pathol
. 2000
Jan
;156
(1
):57
–63
.
[PubMed]
0002-944066.
Hofman
V
, Bonnetaud
C
, Ilie
MI
, Vielh
P
, Vignaud
JM
, Fléjou
JF
, et al.. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker
. Clin Cancer Res
. 2011
Feb
;17
(4
):827
–35
.
[PubMed]
1078-043267.
Lowe
AC
, Pignon
JC
, Carvo
I
, Drage
MG
, Constantine
NM
, Jones
N
, et al.. Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3
. Cancer Cytopathol
. 2015
Dec
;123
(12
):696
–706
.
[PubMed]
1934-662X68.
Pesta
M
, Kulda
V
, Narsanska
A
, Fichtl
J
, Topolcan
O
. May CTC technologies promote better cancer management
. EPMA J
. 2015
Jan
;6
(1
):1
.
[PubMed]
1878-507769.
Gerlinger
M
, Rowan
AJ
, Horswell
S
, Math
M
, Larkin
J
, Endesfelder
D
, et al.. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
. N Engl J Med
. 2012
Mar
;366
(10
):883
–92
.
[PubMed]
0028-479370.
Almendro
V
, Fuster
G
. Heterogeneity of breast cancer: etiology and clinical relevance
. Clin Transl Oncol
. 2011
Nov
;13
(11
):767
–73
.
[PubMed]
1699-048X71.
Camara
O
, Rengsberger
M
, Egbe
A
, Koch
A
, Gajda
M
, Hammer
U
, et al.. The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer
. Ann Oncol
. 2007
Sep
;18
(9
):1484
–92
.
[PubMed]
0923-753472.
Rüdiger
N
, Stein
EL
, Schill
E
, Spitz
G
, Rabenstein
C
, Stauch
M
, et al.. Chemosensitivity Testing of Circulating Epithelial Tumor Cells (CETC) in Vitro: Correlation to in Vivo Sensitivity and Clinical Outcome
. J Cancer Ther
. 2013
;4
(02
):597
–605
. 2151-193473.
Gallant
JN
, Matthew
EM
, Cheng
H
, Harouaka
R
, Lamparella
NE
, Kunkel
M
, et al.. Predicting therapy response in live tumor cells isolated with the flexible micro spring array device
. Cell Cycle
. 2013
Jul
;12
(13
):2132
–43
.
[PubMed]
1538-410174.
Yu
M
, Bardia
A
, Aceto
N
, Bersani
F
, Madden
MW
, Donaldson
MC
, et al.. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
. Science
. 2014
Jul
;345
(6193
):216
–20
.
[PubMed]
0036-807575.
Grillet
F
, Bayet
E
, Villeronce
O
, et al.. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture
. Gut
. 2016
; [Epub ahead of print
].
[PubMed]
0017-574976.
Toss
A
, Mu
Z
, Fernandez
S
, Cristofanilli
M
. CTC enumeration and characterization: moving toward personalized medicine
. Ann Transl Med
. 2014
Nov
;2
(11
):108
.
[PubMed]
2305-583977.
Stebbing
J
, Payne
R
, Reise
J
, Frampton
AE
, Avery
M
, Woodley
L
, et al.. The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study
. PLoS One
. 2013
May
;8
(5
):e62543
.
[PubMed]
1932-620378.
Bidard
FC
, Fehm
T
, Ignatiadis
M
, Smerage
JB
, Alix-Panabières
C
, Janni
W
, et al.. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
. Cancer Metastasis Rev
. 2013
Jun
;32
(1-2
):179
–88
.
[PubMed]
0167-765979.
Zhang
Y
, Zhang
X
, Zhang
J
, Sun
B
, Zheng
L
, Li
J
, et al.. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay
. Cancer Biol Ther
. 2016
Nov
;17
(11
):1177
–87
.
[PubMed]
1538-404780.
Hughes
AD
, Marshall
JR
, Keller
E
, Powderly
JD
, Greene
BT
, King
MR
. Differential drug responses of circulating tumor cells within patient blood
. Cancer Lett
. 2014
Sep
;352
(1
):28
–35
.
[PubMed]
0304-383581.
Cristofanilli
M
, Budd
GT
, Ellis
MJ
, Stopeck
A
, Matera
J
, Miller
MC
, et al.. Circulating tumor cells, disease progression, and survival in metastatic breast cancer
. N Engl J Med
. 2004
Aug
;351
(8
):781
–91
.
[PubMed]
0028-479382.
Abbott
A
. Cell culture: biology’s new dimension
. Nature
. 2003
Aug
;424
(6951
):870
–2
.
[PubMed]
0028-083683.
Smalley
KS
, Lioni
M
, Herlyn
M
. Life isn’t flat: taking cancer biology to the next dimension
. In Vitro Cell Dev Biol Anim
. 2006
Sep-Oct
;42
(8-9
):242
–7
.
[PubMed]
1071-269084.
Weigelt
B
, Bissell
MJ
. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer
. Semin Cancer Biol
. 2008
Oct
;18
(5
):311
–21
.
[PubMed]
1044-579X85.
Xu
F
, Burg
KJ
. Three-dimensional polymeric systems for cancer cell studies
. Cytotechnology
. 2007
Jul
;54
(3
):135
–43
.
[PubMed]
0920-906986.
Page
H
, Flood
P
, Reynaud
EG
. Three-dimensional tissue cultures: current trends and beyond
. Cell Tissue Res
. 2013
Apr
;352
(1
):123
–31
.
[PubMed]
0302-766X87.
Breslin
S
, O’Driscoll
L
. Three-dimensional cell culture: the missing link in drug discovery
. Drug Discov Today
. 2013
Mar
;18
(5-6
):240
–9
.
[PubMed]
1359-644688.
Yamada
KM
, Cukierman
E
. Modeling tissue morphogenesis and cancer in 3D
. Cell
. 2007
Aug
;130
(4
):601
–10
.
[PubMed]
0092-867489.
Valyi-Nagy
K
, Voros
A
, Gagyi
E
, Valyi-Nagy
T
. Increased Resistance of Vasculogenic Mimicry-Forming Uveal Melanoma Cells against Cytotoxic Agents in Three-Dimensional
. Cult Tech
. 2011
;18
:377
–92
. 0223-438690.
Mueller-Klieser
W
, Freyer
JP
, Sutherland
RM
. Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids
. Br J Cancer
. 1986
Mar
;53
(3
):345
–53
.
[PubMed]
0007-092091.
Frieboes
HB
, Zheng
X
, Sun
CH
, Tromberg
B
, Gatenby
R
, Cristini
V
. An integrated computational/experimental model of tumor invasion
. Cancer Res
. 2006
Feb
;66
(3
):1597
–604
.
[PubMed]
0008-547292.
Dawson
E
, Mapili
G
, Erickson
K
, Taqvi
S
, Roy
K
. Biomaterials for stem cell differentiation
. Adv Drug Deliv Rev
. 2008
Jan
;60
(2
):215
–28
.
[PubMed]
0169-409X93.
Tibbitt
MW
, Anseth
KS
. Hydrogels as extracellular matrix mimics for 3D cell culture
. Biotechnol Bioeng
. 2009
Jul
;103
(4
):655
–63
.
[PubMed]
0006-359294.
Gurski
LA
, Petrelli
NJ
, Jia
X
, Farach-Carson
MC
. 3D matrices for anti-cancer drug testing and development
. Oncology Issues
. 2010
;25
(1
):20
–5
. 95.
Valent
P
, Bonnet
D
, De Maria
R
, Lapidot
T
, Copland
M
, Melo
JV
, et al.. Cancer stem cell definitions and terminology: the devil is in the details
. Nat Rev Cancer
. 2012
Nov
;12
(11
):767
–75
.
[PubMed]
1474-175X96.
Bichsel
CA
, Gobaa
S
, Kobel
S
, Secondini
C
, Thalmann
GN
, Cecchini
MG
, et al.. Diagnostic microchip to assay 3D colony-growth potential of captured circulating tumor cells
. Lab Chip
. 2012
Jul
;12
(13
):2313
–6
.
[PubMed]
1473-019797.
Stakenborg
T
, Liu
C
, Henry
O
, Borgen
E
, Laddach
N
, Roeser
T
, et al.. Automated genotyping of circulating tumor cells
. Expert Rev Mol Diagn
. 2010
Sep
;10
(6
):723
–9
.
[PubMed]
1473-715998.
Hirschhaeuser
F
, Menne
H
, Dittfeld
C
, West
J
, Mueller-Klieser
W
, Kunz-Schughart
LA
. Multicellular tumor spheroids: an underestimated tool is catching up again
. J Biotechnol
. 2010
Jul
;148
(1
):3
–15
.
[PubMed]
0168-165699.
Friedrich
J
, Seidel
C
, Ebner
R
, Kunz-Schughart
LA
. Spheroid-based drug screen: considerations and practical approach
. Nat Protoc
. 2009
;4
(3
):309
–24
.
[PubMed]
1754-2189100.
Härmä
V
, Virtanen
J
, Mäkelä
R
, Happonen
A
, Mpindi
JP
, Knuuttila
M
, et al.. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses
. PLoS One
. 2010
May
;5
(5
):e10431
.
[PubMed]
1932-6203101.
Ross
AA
, Cooper
BW
, Lazarus
HM
, Mackay
W
, Moss
TJ
, Ciobanu
N
, et al.. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques
. Blood
. 1993
Nov
;82
(9
):2605
–10
.
[PubMed]
0006-4971102.
Theodoropoulos
PA
, Polioudaki
H
, Agelaki
S
, Kallergi
G
, Saridaki
Z
, Mavroudis
D
, et al.. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
. Cancer Lett
. 2010
Feb
;288
(1
):99
–106
.
[PubMed]
0304-3835103.
Ma
J
, Lin
JY
, Alloo
A
, Wilson
BJ
, Schatton
T
, Zhan
Q
, et al.. Isolation of tumorigenic circulating melanoma cells
. Biochem Biophys Res Commun
. 2010
Nov
;402
(4
):711
–7
.
[PubMed]
0006-291X104.
Kasimir-Bauer
S
, Hoffmann
O
, Wallwiener
D
, Kimmig
R
, Fehm
T
. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
. Breast Cancer Res
. 2012
Jan
;14
(1
):R15
.
[PubMed]
1465-5411105.
Economos
C
, Morrissey
C
, Vessella
RL
. Circulating tumor cells as a marker of response: implications for determining treatment efficacy and evaluating new agents
. Curr Opin Urol
. 2012
May
;22
(3
):190
–6
.
[PubMed]
0963-0643106.
Zhang
Z
, Shiratsuchi
H
, Lin
J
, Chen
G
, Reddy
RM
, Azizi
E
, et al.. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
. Oncotarget
. 2014
Dec
;5
(23
):12383
–97
.
[PubMed]
1949-2553107.
Kang
JH
, Krause
S
, Tobin
H
, Mammoto
A
, Kanapathipillai
M
, Ingber
DE
. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells
. Lab Chip
. 2012
Jun
;12
(12
):2175
–81
.
[PubMed]
1473-0197108.
Infanger
DW
, Lynch
ME
, Fischbach
C
. Engineered culture models for studies of tumor-microenvironment interactions
. Annu Rev Biomed Eng
. 2013
;15
(1
):29
–53
.
[PubMed]
1523-9829109.
Zhu
C
, Yago
T
, Lou
J
, Zarnitsyna
VI
, McEver
RP
. Mechanisms for flow-enhanced cell adhesion
. Ann Biomed Eng
. 2008
Apr
;36
(4
):604
–21
.
[PubMed]
0090-6964110.
Chang
KC
, Hammer
DA
. The forward rate of binding of surface-tethered reactants: effect of relative motion between two surfaces
. Biophys J
. 1999
Mar
;76
(3
):1280
–92
.
[PubMed]
0006-3495111.
Lim
YC
, Garcia-Cardena
G
, Allport
JR
, Zervoglos
M
, Connolly
AJ
, Gimbrone
MA
Jr, et al.. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment
. Am J Pathol
. 2003
May
;162
(5
):1591
–601
.
[PubMed]
0002-9440112.
Hida
K
, Hida
Y
, Amin
DN
, Flint
AF
, Panigrahy
D
, Morton
CC
, et al.. Tumor-associated endothelial cells with cytogenetic abnormalities
. Cancer Res
. 2004
Nov
;64
(22
):8249
–55
.
[PubMed]
0008-5472113.
Gao
D
, Vela
I
, Sboner
A
, Iaquinta
PJ
, Karthaus
WR
, Gopalan
A
, et al.. Organoid cultures derived from patients with advanced prostate cancer
. Cell
. 2014
Sep
;159
(1
):176
–87
.
[PubMed]
0092-8674114.
Sachs
N
, Clevers
H
. Organoid cultures for the analysis of cancer phenotypes
. Curr Opin Genet Dev
. 2014
Feb
;24
:68
–73
.
[PubMed]
0959-437X115.
Broutier
L
, Andersson-Rolf
A
, Hindley
CJ
, Boj
SF
, Clevers
H
, Koo
BK
, et al.. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation
. Nat Protoc
. 2016
Sep
;11
(9
):1724
–43
.
[PubMed]
1754-2189116.
Pizon
M
, Schott
D
, Pachmann
U
, Pachmann
K
. The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer
. Oncotarget
. 2016
Jul
;7
(30
):48143
–54
.; Epub ahead of print
.
[PubMed]
1949-2553117.
Barriere
G
, Fici
P
, Gallerani
G
, Fabbri
F
, Zoli
W
, Rigaud
M
. Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations
. Ann Transl Med
. 2014
Nov
;2
(11
):109
.
[PubMed]
2305-5839118.
Li
J
, Shi
L
, Zhang
X
, Sun
B
, Yang
Y
, Ge
N
, et al.. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma
. Oncotarget
. 2016
Jan
;7
(3
):2646
–59
.
[PubMed]
1949-2553119.
Lovitt
CJ
, Shelper
TB
, Avery
VM
. Miniaturized three-dimensional cancer model for drug evaluation
. Assay Drug Dev Technol
. 2013
Sep
;11
(7
):435
–48
.
[PubMed]
1540-658X120.
Pantel
K
, Alix-Panabières
C
. Cell lines from circulating tumor cells
. Oncoscience
. 2015
Aug
;2
(10
):815
–6
.
[PubMed]
2331-4737121.
Kulasinghe
A
, Perry
C
, Warkiani
ME
, Blick
T
, Davies
A
, O’Byrne
K
, et al.. Short term ex-vivo expansion of circulating head and neck tumour cells
. Oncotarget
. 2016
Sep
;7
(37
):60101
–9
.; Epub ahead of print
.
[PubMed]
1949-2553122.
Mishra
DK
, Scott
KL
, Wardwell-Ozgo
JM
, Thrall
MJ
, Kim
MP
. Circulating tumor cells from 4D model have less integrin beta 4 expression
. J Surg Res
. 2015
Feb
;193
(2
):745
–53
.
[PubMed]
0022-4804123.
Ravi
M
, Paramesh
V
, Kaviya
SR
, Anuradha
E
, Solomon
FD
. 3D cell culture systems: advantages and applications
. J Cell Physiol
. 2015
Jan
;230
(1
):16
–26
.
[PubMed]
0021-9541© 2019 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2019
You do not currently have access to this content.
